Actinium Pharmaceuticals, Inc. (ATNM) › Total LiabilitiesActinium Pharmaceuticals, Inc. (ATNM) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2010: $94.8K2011: $84.5K2012: $4.64M2013: $7.33M2014: $9.49M2015: $4.61M2016: $4.52M2017: $4.67M2018: $6.08M2019: $6.03M2020: $5.08M2021: $6.84M2022: $47.71M2023: $45.07M2024: $44.14M2025: $43.94M$43.94M2010Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$43.94M-0.5%2024$44.14M-2.1%2023$45.07M-5.5%2022$47.71M+597.2%2021$6.84M+34.8%2020$5.08M-15.7%2019$6.03M-0.8%2018$6.08M+30.2%2017$4.67M+3.2%2016$4.52M-2.0%2015$4.61M-51.4%2014$9.49M+29.6%2013$7.33M+57.8%2012$4.64M+5396.3%2011$84.5K-10.9%2010$94.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share